These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9353591)

  • 41. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.
    Havlícek L; Hanus J; Veselý J; Leclerc S; Meijer L; Shaw G; Strnad M
    J Med Chem; 1997 Feb; 40(4):408-12. PubMed ID: 9046330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases.
    Vermeulen K; Strnad M; Krystof V; Havlícek L; Van der Aa A; Lenjou M; Nijs G; Rodrigus I; Stockman B; van Onckelen H; Van Bockstaele DR; Berneman ZN
    Leukemia; 2002 Mar; 16(3):299-305. PubMed ID: 11896531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of cycloheximide, 6-DMAP, roscovitine and butyrolactone I on resumption of meiosis in porcine oocytes.
    Le Beux G; Richard FJ; Sirard MA
    Theriogenology; 2003 Oct; 60(6):1049-58. PubMed ID: 12935845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclin H activation and drug susceptibility of the Pfmrk cyclin dependent protein kinase from Plasmodium falciparum.
    Waters NC; Woodard CL; Prigge ST
    Mol Biochem Parasitol; 2000 Mar; 107(1):45-55. PubMed ID: 10717301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
    Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
    Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and biological activities of C-2, N-9 substituted 6-benzylaminopurine derivatives as cyclin-dependent kinase inhibitor.
    Oh CH; Lee SC; Lee KS; Woo ER; Hong CY; Yang BS; Baek DJ; Cho JH
    Arch Pharm (Weinheim); 1999 Jun; 332(6):187-90. PubMed ID: 10399486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinase inhibition lengthens the period of the circadian pacemaker in the eye of Bulla gouldiana.
    Roberts MH; Bedian V; Chen YL
    Brain Res; 1989 Dec; 504(2):211-5. PubMed ID: 2598024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension.
    Planchais S; Glab N; Tréhin C; Perennes C; Bureau JM; Meijer L; Bergounioux C
    Plant J; 1997 Jul; 12(1):191-202. PubMed ID: 9263460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional p53 in cells contributes to the anticancer effect of the cyclin-dependent kinase inhibitor roscovitine.
    Paprskárová M; Krystof V; Jorda R; Dzubák P; Hajdúch M; Wesierska-Gadek J; Strnad M
    J Cell Biochem; 2009 Jun; 107(3):428-37. PubMed ID: 19308936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib.
    Iurisci I; Filipski E; Sallam H; Harper F; Guettier C; Maire I; Hassan M; Iacobelli S; Lévi F
    Chronobiol Int; 2009 Aug; 26(6):1169-88. PubMed ID: 19731111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Caspase 8/10 are not mediating apoptosis in neuroblastoma cells treated with CDK inhibitory drugs.
    Ribas J; Gomez-Arbones X; Boix J
    Eur J Pharmacol; 2005 Nov; 524(1-3):49-52. PubMed ID: 16243312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CDK inhibitors suppress apoptosis induced by chemicals and by excessive expression of a cell death gene, reaper, in Drosophila cells.
    Nagano M; Ui-Tei K; Suzuki H; Piao Z; Miyata Y
    Apoptosis; 2000 Dec; 5(6):543-50. PubMed ID: 11303913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circadian rhythm from the eye of Aplysia: temperature compensation of the effects of protein synthesis inhibitors.
    Jacklet JW
    J Exp Biol; 1980 Feb; 84():1-15. PubMed ID: 7365411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell cycle inhibitor enhances the resolution of HSV-1-induced proinflammatory response in murine microglial cells.
    Zhou Y; Guo YJ; Liu X; Mei YW
    Neurol Res; 2009 Nov; 31(9):910-6. PubMed ID: 19138471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of circadian rhythm on pharmacokinetics and metabolism of the Cdk inhibitor, roscovitine, in tumor mice model.
    Sallam H; El-Serafi AT; Filipski E; Terelius Y; Lévi F; Hassan M
    Chronobiol Int; 2015 Jun; 32(5):608-14. PubMed ID: 25938685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of olomoucine, a selective inhibitor of cyclin-dependent kinases, on cell cycle progression in human cancer cell lines.
    Buquet-Fagot C; Lallemand F; Montagne MN; Mester J
    Anticancer Drugs; 1997 Jul; 8(6):623-31. PubMed ID: 9300578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.
    Kudoh A; Daikoku T; Sugaya Y; Isomura H; Fujita M; Kiyono T; Nishiyama Y; Tsurumi T
    J Virol; 2004 Jan; 78(1):104-15. PubMed ID: 14671092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cdk inhibition in human cells compromises chk1 function and activates a DNA damage response.
    Maude SL; Enders GH
    Cancer Res; 2005 Feb; 65(3):780-6. PubMed ID: 15705874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells.
    Zhang W; Lee JC; Kumar S; Gowen M
    J Bone Miner Res; 1999 Apr; 14(4):528-35. PubMed ID: 10234573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation.
    Leitch AE; Lucas CD; Marwick JA; Duffin R; Haslett C; Rossi AG
    Cell Death Differ; 2012 Dec; 19(12):1950-61. PubMed ID: 22743999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.